Published in Leukemia on April 16, 2012
Challenges in using circulating miRNAs as cancer biomarkers. Biomed Res Int (2015) 1.08
Cell-free microRNAs: potential biomarkers in need of standardized reporting. Front Genet (2013) 0.97
The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem (2014) 0.90
Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients. PLoS One (2014) 0.90
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. Leukemia (2013) 0.88
Circulating MicroRNAs: Association with Lung Function in Asthma. PLoS One (2016) 0.85
Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods. Mol Biol Rep (2016) 0.79
Determination of abnormally expressed microRNAs in bone marrow smears from patients with follicular lymphomas. Springerplus (2014) 0.77
MicroRNA-derived fragment length polymorphism assay. Sci Rep (2015) 0.75
Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs. J Vet Intern Med (2016) 0.75
MicroRNAs as Novel Biomarkers of Deployment Status and Exposure to Polychlorinated Dibenzo-p-Dioxins/Dibenzofurans. J Occup Environ Med (2016) 0.75
Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. PLoS One (2017) 0.75
Circulating microRNAs and association with methacholine PC20 in the Childhood Asthma Management Program (CAMP) cohort. PLoS One (2017) 0.75
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet (2010) 10.97
Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res (2008) 10.18
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer (1997) 8.27
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia (2009) 4.91
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med (2009) 4.03
Photosynthetic O2 formation tracked by time-resolved x-ray experiments. Science (2005) 3.35
Isolation of peroxisome-deficient mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1989) 2.80
Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet (1993) 2.64
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol (2010) 2.39
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology (2012) 2.23
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia (2004) 2.08
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol (1996) 2.05
Deterministic quantum teleportation of atomic qubits. Nature (2004) 2.05
Randomized clinical trial comparing lightweight composite mesh with polyester or polypropylene mesh for incisional hernia repair. Br J Surg (2005) 2.05
Spectroscopy using quantum logic. Science (2005) 2.04
[Evaluation of the Freiburg monosyllabic speech test in background noise]. HNO (2013) 2.04
Realization of quantum error correction. Nature (2004) 2.03
DNMT3A mutations in myeloproliferative neoplasms. Leukemia (2011) 1.95
Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol (2003) 1.94
The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci (1998) 1.92
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia (2009) 1.92
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood (2009) 1.89
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene (1998) 1.81
CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology (2010) 1.77
Experimental demonstration of a robust, high-fidelity geometric two ion-qubit phase gate. Nature (2003) 1.77
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell (2006) 1.74
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett (1997) 1.71
B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet (2001) 1.70
Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology (2006) 1.69
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia (2012) 1.68
The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol (2013) 1.67
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol (2004) 1.62
Toward Heisenberg-limited spectroscopy with multiparticle entangled states. Science (2004) 1.61
Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood (1999) 1.55
Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet (1993) 1.52
Prevalence and risk factors of focal sparing in hepatic steatosis. Ultraschall Med (2010) 1.50
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer (2001) 1.49
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A (2000) 1.46
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia (2007) 1.43
Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol (2010) 1.43
Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer (1998) 1.42
[The carcinogenic potential of biomaterials in hernia surgery]. Chirurg (2002) 1.41
APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol (1993) 1.39
Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact. Leukemia (2000) 1.39
Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer (1999) 1.39
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood (2007) 1.37
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood (2010) 1.36
Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood (1998) 1.36
Creation of a six-atom 'Schrödinger cat' state. Nature (2005) 1.36
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia (2012) 1.36
Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia (2002) 1.33
Primary structure and function of a second essential member of the heterooligomeric TCP1 chaperonin complex of yeast, TCP1 beta. Proc Natl Acad Sci U S A (1994) 1.32
An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. J Pathol (2007) 1.32
Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem (2001) 1.29
Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging (2002) 1.28
[The experience of family carers of older people in the use of support services in Europe: selected findings from the EUROFAMCARE project]. Z Gerontol Geriatr (2006) 1.27
MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol (2010) 1.25
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. Cancer Cell (2011) 1.25
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.24
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int J Radiat Oncol Biol Phys (2000) 1.23
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer (2001) 1.23
Microfabricated surface-electrode ion trap for scalable quantum information processing. Phys Rev Lett (2006) 1.21
Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol (1995) 1.20
Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood (1997) 1.19
Entangled mechanical oscillators. Nature (2009) 1.19
CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol (2012) 1.19
Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. Blood (2013) 1.19
BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts. Leukemia (2007) 1.18
Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother (2006) 1.16
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia (2009) 1.16
Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling. J Cell Mol Med (2008) 1.15
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia (2010) 1.15
Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med (1997) 1.13
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia (2008) 1.13
Evaluation of EGFR mutation status in cytology specimens: an institutional experience. Diagn Cytopathol (2011) 1.12
Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood (1995) 1.12
Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer (1999) 1.11
[Cocaine-body-packing. Infrequent indication for laparotomy]. Chirurg (2003) 1.11
Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q). Genes Chromosomes Cancer (1999) 1.10
Mesh penetration of the sigmoid colon following a transabdominal preperitoneal hernia repair. Surg Endosc (2002) 1.09
miRNA*: a passenger stranded in RNA-induced silencing complex? Crit Rev Eukaryot Gene Expr (2010) 1.09
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma. Leukemia (2008) 1.08
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia (2003) 1.08
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08
Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. Exp Hematol (2008) 1.05